Open Innovation to Fill Pharma’s Pipelines
The medcitynews website reported that open innovation and cooperation in the pharmaceutical industry will continue to gain traction as patent losses and R&D cutbacks force drug companies to look outside of their own walls for promising technologies, according to a new report from GBI Research.
Click here to read the full article.